- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Diet, High Protein in Japan
Total 272 results
-
Celgene CorporationTerminatedAcute Myeloid Leukemia | Myelodysplastic Syndromes | Multiple Myeloma | Hodgkin Lymphoma | Chronic Myelomonocytic Leukemia | Non-Hodgkin LymphomaJapan
-
Baxalta now part of ShireBaxter Innovations GmbHCompleted
-
Otsuka Pharmaceutical Co., Ltd.RecruitingMultiple Myeloma (MM)Japan
-
Gilead SciencesCompletedFollicular Lymphoma | Marginal Zone Lymphoma | Chronic Lymphocytic Leukemia | Small Lymphocytic Lymphoma | Indolent Non-Hodgkin Lymphoma | Lymphoplasmacytic Lymphoma (With or Without Waldenstrom Macroglobulinemia)Japan
-
CelgeneCompleted
-
Kiminori Kimura, MDJapan Agency for Medical Research and DevelopmentRecruiting
-
National University Hospital, SingaporeCelgene; International Myeloma FoundationUnknownRelapse Multiple MyelomaSingapore, Hong Kong, Japan, Korea, Republic of, Taiwan
-
Novartis PharmaceuticalsCompletedAML and High Risk MDSGermany, Italy, France, Netherlands, United States, Australia, Japan
-
Celgene CorporationCompleted
-
Novartis PharmaceuticalsCompleted
-
AmgenCompletedHypercholesterolemia and High Risk for Cardiovascular EventsJapan
-
Sumitomo Pharma America, Inc.Active, not recruitingGlioblastoma Multiforme | High Grade GliomaUnited States, Japan
-
Eli Lilly and CompanyTerminatedHepatocellular Carcinoma | Solid Tumor | Gastric Adenocarcinoma | Leiomyosarcoma | Head and Neck Squamous Cell Carcinoma | Cervical Carcinoma | Triple-negative Breast Cancer | Undifferentiated Pleomorphic Sarcoma | High Grade Serous Ovarian CarcinomaUnited States, Japan
-
Janssen Pharmaceutical K.K.CompletedWaldenstrom MacroglobulinemiaJapan
-
Novo Nordisk A/SEnrolling by invitation
-
CelgeneCompletedMultiple MyelomaUnited States, Japan
-
BayerCompletedHemophilia A | Hemophilia BUkraine, United Kingdom, Bulgaria, Germany, Japan
-
Baxalta now part of ShireTakedaCompleted
-
CelgeneCompleted
-
AbbVieActive, not recruiting
-
TakedaCompleted
-
SymBio PharmaceuticalsCompletedRelapsed/Refractory Multiple MyelomaJapan
-
AmgenCompletedHyperlipidemia or Mixed Dyslipidemia at High Risk for Cardiovascular EventsJapan
-
AstraZenecaBristol-Myers SquibbCompletedType 2 Diabetes | High Blood SugarJapan
-
BayerCompletedHemophilia AUnited States, Japan, United Kingdom, Spain
-
AstraZenecaBristol-Myers SquibbCompletedType2 Diabetes | High Blood SugarJapan
-
Janssen Pharmaceutical K.K.Active, not recruitingHematologic MalignanciesJapan
-
Weill Medical College of Cornell UniversityBayer; University Hospital, BonnCompletedHemophilia A | Hemophilia BUnited States, Israel, Australia, Italy, Sweden, Germany, Japan, Netherlands, Taiwan
-
Novo Nordisk A/SCompletedCongenital Bleeding Disorder | Haemophilia AJapan
-
Bioverativ, a Sanofi companyCompletedHemophilia AUnited States, Japan
-
PfizerRecruitingMultiple MyelomaCanada, France, Japan, Australia, United States
-
Hoffmann-La RocheChugai PharmaceuticalCompletedHemophilia AUnited States, Belgium, Spain, Japan, Poland, Australia
-
Novartis PharmaceuticalsTerminatedMyelofibrosis With High Molecular Risk MutationsBelgium, Spain, United Kingdom, Hungary, Italy, Japan, Taiwan, Germany, Canada, Singapore, Austria, Australia, France, Israel, Sweden, Switzerland, Hong Kong, Greece, Turkey, Brazil, Russian Federation, Denmark, Portugal, Norway, Poland
-
CelgeneCompleted
-
Novartis PharmaceuticalsActive, not recruitingMultiple Myeloma (MM)United States, Italy, Israel, Germany, Japan, Spain, Australia, Norway
-
BayerTerminatedHemophilia A and BAustralia, United Kingdom, Taiwan, Japan, Korea, Republic of, Austria, Bulgaria, Hungary, Italy, France, New Zealand
-
Novo Nordisk A/SEnrolling by invitation
-
Janssen Research & Development, LLCCompleted
-
Janssen Pharmaceutical K.K.Completed
-
Baxalta now part of ShireCompletedRecombinant Factor VIIa BI (rFVIIa BI) Treatment of Acute Bleeding Episodes Per an On-demand RegimenHemophilia A | Hemophilia BJapan, Russian Federation, Spain, United States, Poland, Romania, Serbia, Taiwan, Ukraine
-
SanofiCompletedMultiple MyelomaFrance, Spain, Belgium, Australia, United States, Japan
-
SanofiCompleted
-
GlaxoSmithKlineRecruitingMultiple MyelomaAustralia, Poland, Taiwan, Korea, Republic of, Japan, United Kingdom, Brazil, Mexico, Turkey, Argentina
-
Kyowa Kirin Co., Ltd.CompletedMultiple Myeloma and Malignant LymphomaJapan
-
Novartis PharmaceuticalsCompletedMultiple Myeloma (MM), Lymphoma, Large B-Cell, Diffuse (DLBCL), LymphomaItaly, Australia, Germany, Spain, France, Japan, United States
-
TakedaCompletedRelapsed and/or Refractory Multiple MyelomaJapan
-
Baxalta now part of ShireCompletedHemophilia BPoland, United Kingdom, Spain, Bulgaria, Romania, Japan, Russian Federation, Brazil, Chile, Sweden, Colombia, Ukraine, Argentina, Czechia
-
BayerActive, not recruitingHemophilia ACanada, Japan, Spain, United States, Germany, Sweden, Belgium, Brazil, Greece, Italy, Netherlands, Taiwan, Denmark, Kuwait, Saudi Arabia, United Arab Emirates, Norway, Colombia, Switzerland, Slovenia
-
AmgenTerminatedRelapsed and/or Refractory Multiple MyelomaUnited States, Japan, Belgium, Australia, Switzerland
-
SanofiActive, not recruitingRelapsed/Refractory Multiple MyelomaAustralia, Czechia, Brazil, Japan, Greece, Portugal